Stakeholder Opinions: Type 2 Diabetes in the UAE & Saudi Arabia Growth opportunities in fragmented marketsDatamonitorDecember 19, 2008 27 Pages - SKU: DFMN2069254 |
More Drug Discovery reports by Datamonitor
Pipeline: Colorectal Cancer by Datamonitor
IntroductionTargeted therapies continue to dominate the colorectal cancer pipeline. With two new approvals in 2012, drug developers must now move away from anti-VEGF drugs toward ...
The Osteoporosis Market Outlook to 2021 by Datamonitor
IntroductionThe seven major markets are characterized by an aging population and hence the incidence of osteoporosis will increase accordingly. The increase in patient numbers, however, ...
The Osteoporosis Market Forecast to 2021 by Datamonitor
IntroductionThe seven major markets are characterized by an aging population and hence the incidence of osteoporosis will increase accordingly. The increase in patient numbers, however, ...
Pipeline: Renal Cell Cancer by Datamonitor
See all reports like this >>IntroductionSeven targeted therapies are available for the treatment of RCC but there is still considerable pipeline activity. Currently approved targeted therapies have been unable to ...
More United Arab Emirates reports
Country Risk Service United Arab Emirates January 2013 Updater by The Economist Intelligence Unit
Country Risk Service is a comprehensive two-year forecasting service that monitors risks in 100 key emerging markets. It is designed for commercial bankers, institutional investors ...
D&B Country RiskLine Report: The United Arab Emirates by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
United Arab Emirates: Country Profile by MarketLine
See all reports like this >>INTRODUCTIONThis report provides a detailed analysis on the United Arab Emirates (UAE), providing an overview of its political, economic and business environment, represented both textually ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Drug Discovery Reports
- Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer’s Disease
- Central Nervous System Disorder Drugs Markets in China
- Lymphoma Treatment Drugs Markets in China
- Anti-Tumor Drugs Markets in China
- Osteoporosis Treatment Drugs Markets in China
